Cargando…
Clinically significant anticardiolipin antibodies associated with COVID-19
The novel coronavirus strain known as SARS-CoV-2 has rapidly spread around the world creating distinct challenges to the healthcare workforce. Coagulopathy contributing to significant morbidity in critically ill patients with SARS-CoV-2 has now been well documented. We discuss two cases selected fro...
Autores principales: | Hossri, Sami, Shadi, Mahmoud, Hamarsha, Zaid, Schneider, Rick, El-Sayegh, Dany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256550/ https://www.ncbi.nlm.nih.gov/pubmed/32512349 http://dx.doi.org/10.1016/j.jcrc.2020.05.017 |
Ejemplares similares
-
Association of anticardiolipin antibodies with epilepsy in children
por: Shiva, Shadi, et al.
Publicado: (2023) -
352 Anticardiolipin Antibodies in Patients with Acute Myeloid Leukemia: Prevalence and Clinical Significance
por: Ayatollahi, Maryam, et al.
Publicado: (2012) -
Advances in the Research on Anticardiolipin Antibody
por: Wang, Dan, et al.
Publicado: (2019) -
Prevalence and coagulation correlation of anticardiolipin antibodies in patients with COVID-19
por: Zeng, Hui, et al.
Publicado: (2022) -
Primary Pulmonary Hodgkin's Lymphoma: A Rare Etiology of a Cavitary Lung Mass
por: El Hage, Halim, et al.
Publicado: (2017)